109 related articles for article (PubMed ID: 7028697)
1. The quest for a clearer understanding of ovarian carcinoma.
Beecham JB; Knauf SS
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1099-101. PubMed ID: 7028697
[No Abstract] [Full Text] [Related]
2. [Antigenicity of ovarian cancer tissues (author's transl)].
Gong Y
Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):156-8. PubMed ID: 6179584
[No Abstract] [Full Text] [Related]
3. Detection of ovarian cancer by the humoral leukocyte adherence inhibition test using a purified tumor-associated antigen.
Kotlar HK; Knauf S; Beecham J; Kjørstad K; Sanner T
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):483-6. PubMed ID: 3891363
[TBL] [Abstract][Full Text] [Related]
4. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer: evaluation of the leukocyte adherence inhibition assay.
Hicks LJ; Dodd JK; Tyler JP; Hudson CN
Asia Oceania J Obstet Gynaecol; 1984 Dec; 10(4):547-58. PubMed ID: 6085256
[No Abstract] [Full Text] [Related]
6. Tumor antigens in ovarian malignancy.
Rubin SC; Lewis JL
Clin Obstet Gynecol; 1986 Sep; 29(3):693-704. PubMed ID: 2428553
[No Abstract] [Full Text] [Related]
7. Characterization of tumor-associated antigens of ovarian carcinoma.
Knauf S; Urbach GI
Gynecol Oncol; 1976 Jun; 4(2):167-75. PubMed ID: 986342
[No Abstract] [Full Text] [Related]
8. CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
Canney PA; Wilkinson PM; James RD; Moore M
Br J Cancer; 1985 Jul; 52(1):131-3. PubMed ID: 2410004
[No Abstract] [Full Text] [Related]
9. Immunodiagnosis in ovarian cancer: blocking factor activity.
Pattillo RA; Ruckert AC; Story MT; Mattingly RF
Am J Obstet Gynecol; 1979 Apr; 133(7):791-802. PubMed ID: 373445
[TBL] [Abstract][Full Text] [Related]
10. [Leukocyte adherence in women with ovarian carcinoma].
Kobilková J; Jandová A; Pokorný J; Macků J
Ceska Gynekol; 1994 Apr; 59(2):66-9. PubMed ID: 8004373
[TBL] [Abstract][Full Text] [Related]
11. [Possibilities and limitations of the clinical use of specific monoclonal antibodies for epithelial ovarian carcinomas: CA125K].
Pozzi V; D'Onofrio T; Cappa F; Mascaretti G; Meggiorini ML; Nusiner MP; Danese M
Minerva Ginecol; 1985 May; 37(5):253-7. PubMed ID: 3861960
[No Abstract] [Full Text] [Related]
12. [Assay of leucocyte adherence inhibition in patients with ovarian cancer].
Zhang SZ; Cai GR
Zhonghua Fu Chan Ke Za Zhi; 1986 Sep; 21(5):294-7, 319. PubMed ID: 3816401
[No Abstract] [Full Text] [Related]
13. Continued controversies in the diagnosis and treatment of ovarian adenocarcinomas.
Piver MS
J Reprod Med; 1979 Mar; 22(3):119-27. PubMed ID: 108399
[No Abstract] [Full Text] [Related]
14. [Carcinoma of the ovary: reliability of its markers].
Moggian G; Gunelli R; Magrone F; Canali P; Spadazzi AP; Pini PL
Minerva Ginecol; 1988 Jan; 40(1):9-13. PubMed ID: 3163780
[No Abstract] [Full Text] [Related]
15. The value of tumor markers in cancer of the ovary.
Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
[No Abstract] [Full Text] [Related]
16. Cellular DNA content and CA-125 antigen expression in ovarian carcinomas.
Baker VV; Haskill S; Fowler WC; Walton LA; Currie JL
Oncology; 1987; 44(5):283-6. PubMed ID: 3478626
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of epithelial ovarian neoplasm immunologic reactivity using monoclonal antibodies].
Bar J; Sobańska E
Ginekol Pol; 1994 Sep; 65(9):502-7. PubMed ID: 7721163
[TBL] [Abstract][Full Text] [Related]
18. [Clinical aspects and results of treatment of malignant ovarian tumors].
Carol W; Kupfer G
Munch Med Wochenschr; 1965 Nov; 107(47):2348-53. PubMed ID: 5899202
[No Abstract] [Full Text] [Related]
19. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
Patsner B; Mann WJ; Chalas E
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):949-50. PubMed ID: 3163416
[No Abstract] [Full Text] [Related]
20. [Ovarian carcinoma-associated antigen isolated from peritoneal effusions in clinical diagnosis].
Qian HN
Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):242-6. PubMed ID: 6426896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
